According to the TIMER2 database (glioma tissues, n = 153; adjacent normal tissues, n = 5), PSMD9/10/13/14 mRNA expression levels were significantly increased in GBM, while PSMD1 mRNA expression levels were decreased in GBM tissues (Figure 1A). This evidence concerns the gene PSMD9 and central nervous system cancer.